Methylprednisolone Completed Phase 3 Trials for Chronic Subdural Hematomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02650609Treatment of Chronic Subdural Hematoma by Corticosteroids